Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon
The prevalence of colon-associated diseases has increased significantly over the past several decades, as evidenced by accumulated literature on conditions such as Crohn's disease, irritable bowel syndrome, colorectal cancer, and ulcerative colitis. Developing therapeutics for these diseases is...
Saved in:
Main Authors: | Hamid A. Bakshi (Author), Gerry A. Quinn (Author), Alaa A. A. Aljabali (Author), Faruck L. Hakkim (Author), Rabia Farzand (Author), Mohamed M. Nasef (Author), Naji Abuglela (Author), Prawej Ansari (Author), Vijay Mishra (Author), Ángel Serrano-Aroca (Author), Murtaza M. Tambuwala (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fourth‐generation glucose sensors composed of copper nanostructures for diabetes management: A critical review
by: Gowhar A. Naikoo, et al.
Published: (2022) -
Biomedical applications of three‐dimensional bioprinted craniofacial tissue engineering
by: Nitin Bharat Charbe, et al.
Published: (2023) -
Screening and assessment of molecular mechanistic actions of 5-hydroxy-1-methylpiperidin-2-one against free radicals, lung cancer cell line (A549), and binding properties on bovine serum albumin
by: Sangilimuthu Alagar Yadav, et al.
Published: (2021) -
Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database
by: Atul Khurana, et al.
Published: (2024) -
Would New SARS-CoV-2 Variants Change the War against COVID-19?
by: Elrashdy M. Redwan, et al.
Published: (2022)